Samrat Pharma

Samrat_Pharma29 Apr 2024

Pharmaceuticals

₹

-15.55 (-3.73%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Samrat Pharma

Samrat Pharma

Pharmaceuticals

Samrat_Pharma29 Apr 2024

₹

-15.55 (-3.73%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-May-2023	D	Outcome of the Board Meeting of the Company held today. The Company has fixed Monday, September 18, 2023 as the Record Date for the purpose of determining the members eligible to receive dividend of Rs. 1/- per equity share for FY: 2022-23 (As per BSE Announcement Dated on 08/09/2023)	18-Sep-2023
30-May-2022	D	Approval of Audited Financial Results of the Company for the year ended March 31, 2022 Recommendation of Dividend @ 10% on Subscribed Capital of the company Fixing of Date of AGM - 30/09/2022 Closure of Register of Members - 23/09/2022 To 30/09/2022	22-Sep-2022
28-Mar-2024	BC	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Standalone Financial Result	30-May-2024
05-Mar-2024	BC	Postal Ballot Notice with Explanatory Statement Voting Results of the Postal Ballot activity through remote e-voting and the Report of Scrutinizer Outcome of postal ballot remote e-voting & scr	06-Apr-2024
29-Dec-2023	BC	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(2) of the SEB	14-Feb-2024
26-Sep-2023	BC	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the un-audited standalone financial res	08-Nov-2023
30-May-2023	BC	Outcome of the Board Meeting of the Company held today The 31st AGM of the Company will be held on Monday, September 25, 2023 at 02:00 PM (IST) through Video Conferencing / Other Audio Visual Mean	25-Sep-2023

No Rights has been declared by Samrat_Pharma

Book Closure

Record Date	Split Date	Purpose
30-May-2024	-	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Standalone Financial Result
06-Apr-2024	01 Jan'1900	Postal Ballot Notice with Explanatory Statement Voting Results of the Postal Ballot activity through remote e-voting and the Report of Scrutinizer Outcome of postal ballot remote e-voting & scr
14-Feb-2024	-	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(2) of the SEB
08-Nov-2023	-	SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the un-audited standalone financial res
25-Sep-2023	-	Outcome of the Board Meeting of the Company held today The 31st AGM of the Company will be held on Monday, September 25, 2023 at 02:00 PM (IST) through Video Conferencing / Other Audio Visual Mean

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Samrat Pharmachem Ltd ₹400.85(-15.55/-3.73%)	400.85	-15.55	128.67	-26.84	0.00	2.03
Astrazeneca Pharma India Ltd ₹5,550.00(+134.60/2.49%)	5,550.00	+134.60	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,264.85(+400.00/1.55%)	26,264.85	+400.00	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹710.40(+29.55/4.34%)	710.40	+29.55	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	61.67	79.74	57.48	69.18	83.85	71.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	61.67	79.74	57.48	69.18	83.85	71.12
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.42	0.30	0.36	0.03	0.28	0.14
Total Income	62.09	80.04	57.84	69.21	84.13	71.26
Total Expenditure	61.56	79.51	56.71	69.67	80.57	62.86
PBIDT	0.53	0.53	1.13	-0.46	3.56	8.40
Interest	0.23	0.13	0.22	0.17	0.62	0.22
PBDT	0.30	0.40	0.91	-0.63	2.94	8.18
Depreciation	0.16	0.16	0.16	0.16	0.16	0.16
Tax	0.11	0.06	0.19	0.36	0.40	2.22
Deferred Tax	-0.31	0.36	-0.05	-0.41	0.28	-0.11
Reported Profit After Tax	0.34	-0.19	0.61	-0.74	2.10	5.91
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.34	-0.19	0.61	-0.74	2.10	5.91

EPS (Unit Curr.)	1.11	-0.61	1.98	-2.41	6.78	19.14
EPS (Adj) (Unit Curr.)	1.11	-0.61	1.98	-2.41	6.78	19.14
Calculated EPS (Unit Curr.)	1.11	-0.61	1.98	-2.41	6.78	19.14
Calculated EPS (Adj) (Unit Curr.)	1.11	-0.61	1.98	-2.41	6.78	19.14
Calculated EPS (Ann.) (Unit Curr.)	4.46	-2.44	7.91	-9.64	27.14	76.55
Calculated EPS (Adj) (Ann.) (Unit Curr.)	4.46	-2.44	7.91	-9.64	27.14	76.55
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.09	3.09	3.09	3.09	3.09	3.09
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.86	0.66	1.97	-0.66	4.25	11.81
PBDTM(%)	0.49	0.50	1.58	-0.91	3.51	11.50
PATM(%)	0.55	-0.24	1.06	-1.07	2.50	8.31

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.09	3.09	3.09	3.09	3.09	3.09
Reserves Total	60.05	43.73	26.55	21.21	16.98	15.44
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	63.14	46.82	29.64	24.30	20.07	18.53
Secured Loans	18.66	7.52	8.79	9.41	6.53	9.39
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	18.66	7.52	8.79	9.41	6.53	9.39
Total Liabilities	81.80	54.34	38.43	33.71	26.60	27.92
APPLICATION OF FUNDS :
Gross Block	16.25	14.89	14.00	11.44	10.92	10.62
Less : Accumulated Depreciation	5.55	4.91	4.60	4.25	4.05	3.63
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	10.70	9.98	9.40	7.19	6.87	6.99
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	1.08	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.88	0.01	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	32.53	12.42	11.40	18.77	7.93	6.85
Sundry Debtors	51.24	43.57	33.01	27.81	21.05	21.89
Cash and Bank	11.89	14.71	2.51	1.17	2.25	3.98
Loans and Advances	2.94	0.56	0.41	1.93	1.53	0.55
Total Current Assets	98.60	71.25	47.32	49.68	32.76	33.27
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	31.96	24.28	17.83	23.28	12.74	10.98
Provisions	2.14	5.53	0.70	1.22	0.37	1.41
Total Current Liabilities	34.10	29.81	18.53	24.49	13.11	12.39
Net Current Assets	64.50	41.44	28.79	25.18	19.65	20.87
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.43	0.14	0.10	0.33	0.17	0.16
Deferred Tax Liability	0.68	0.60	0.53	0.47	0.49	0.48
Net Deferred Tax	-0.25	-0.46	-0.43	-0.14	-0.32	-0.32
Total Assets	76.83	50.98	37.76	33.31	26.19	27.54
Contingent Liabilities	0.07	0.07	0.07	0.07	0.43	0.36

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	14.71	0.24	0.26	1.50	0.87
Net Cash from Operating Activities	-9.44	17.47	4.80	-1.33	2.37
Net Cash Used In Investing Activities	-3.01	-1.06	-2.92	-1.92	2.18
Net Cash Used In Financing Activities	9.60	-1.95	-1.89	2.00	-3.92
Net Inc./Dec In Cash And Cash Equivalents	-2.84	14.46	-0.02	-1.25	0.63
Cash And Cash Equivalents At End Of The Year	11.86	14.71	0.24	0.26	1.50

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

48.64%

FII Shareholding

0.00%

DII Shareholding

0.22%

Public Shareholding

47.91%

**Promoter pledged shareholding 48.64%

About Samrat Pharmachem Ltd

Samrat Pharmachem Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 128.67 crores. It has reported a sales of Rs. 61.67 crores and a net profit of Rs. 0.34 crores for the quarter ended December 2018. The company management includes Lalit Mehta, Lalit Mehta,Rajesh Mehta,Mahendra Pipalia,Samir Kothary,Renu P Dharod,Megh Mehta,Nishant Kankaria (Samrat Pharmachem Ltd) among others.

Chairman

Lalit Mehta

Registered office

Plot No A2/3445,GIDC Phase IV,Ankleshwar,Gujarat,393002

FAX :91-2646-251291

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy Samrat Pharma shares on nse?

To buy Samrat Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Samrat Pharma share price today?

The Samrat Pharma shares price on nse is Rs.400.85 today.

What is the market cap of Samrat Pharma shares on BSE ?

The company has a market capitalization of Rs.128.67Cr

What is the PE & PB ratio of Samrat Pharma shares ?

PE is 0 and PB is 2.03

What is the 52 Week High and Low of Samrat Pharma shares?

Samrat Pharma stock price high: Rs.594 Samrat Pharma stock price low: Rs.320